reddit semaglutide free speech SemaglutideFreeSpeech Semaglutide
Description
In neuroendocrine tumor management, patients with insulinoma may be at risk of severe hypoglycemia following receipt of GLP-1 receptor agonists.
Amongst, overweight and obese patients defined by BMI in 2024 (58.9% [95% CIs 53.3-64.2%] female [182/309], median [IQR] age 56.6 [46.2-66.1]) GLP 1RA use has increased from 3.2% (10/309 [95% CIs 1.8-5.9%]) to 13.6% (42/309 [95% CIs 10.2-17.9%] [p=7.1x10-6])
This product is not intended to diagnose, treat, cure or prevent any diseases
But how exactly are these
Not intended to diagnose, treat, cure, or prevent any disease
Why not to try?
